thymidine has been researched along with chir-265 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aardalen, K; Aziz, N; Gambhir, SS; Hughes, NP; Kaplan, A; Stuart, D; Tseng, JR | 1 |
1 other study(ies) available for thymidine and chir-265
Article | Year |
---|---|
Use of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B-Raf/VEGFR-2 inhibitor.
Topics: Animals; Biomarkers, Tumor; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glucose; Humans; Imidazoles; Immunoenzyme Techniques; Leukemia, Myeloid, Acute; Melanoma; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins B-raf; Pyridines; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidine; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2011 |